IBDEI2LT ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,41593,1,3,0)
;;=3^Aphasia following cerebral infarction
;;^UTILITY(U,$J,358.3,41593,1,4,0)
;;=4^I69.320
;;^UTILITY(U,$J,358.3,41593,2)
;;=^5007491
;;^UTILITY(U,$J,358.3,41594,0)
;;=I69.120^^155^2061^3
;;^UTILITY(U,$J,358.3,41594,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41594,1,3,0)
;;=3^Aphasia following nontraumatic intracerebral hemorrhage
;;^UTILITY(U,$J,358.3,41594,1,4,0)
;;=4^I69.120
;;^UTILITY(U,$J,358.3,41594,2)
;;=^5007427
;;^UTILITY(U,$J,358.3,41595,0)
;;=I69.020^^155^2061^4
;;^UTILITY(U,$J,358.3,41595,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41595,1,3,0)
;;=3^Aphasia following nontraumatic subarachnoid hemorrhage
;;^UTILITY(U,$J,358.3,41595,1,4,0)
;;=4^I69.020
;;^UTILITY(U,$J,358.3,41595,2)
;;=^5007395
;;^UTILITY(U,$J,358.3,41596,0)
;;=I69.820^^155^2061^5
;;^UTILITY(U,$J,358.3,41596,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41596,1,3,0)
;;=3^Aphasia following other cerebrovascular disease
;;^UTILITY(U,$J,358.3,41596,1,4,0)
;;=4^I69.820
;;^UTILITY(U,$J,358.3,41596,2)
;;=^5007522
;;^UTILITY(U,$J,358.3,41597,0)
;;=I69.220^^155^2061^6
;;^UTILITY(U,$J,358.3,41597,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41597,1,3,0)
;;=3^Aphasia following other nontraumatic intracranial hemorrhage
;;^UTILITY(U,$J,358.3,41597,1,4,0)
;;=4^I69.220
;;^UTILITY(U,$J,358.3,41597,2)
;;=^5007459
;;^UTILITY(U,$J,358.3,41598,0)
;;=I69.290^^155^2061^11
;;^UTILITY(U,$J,358.3,41598,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41598,1,3,0)
;;=3^Apraxia following other nontraumatic intracranial hemorrhage
;;^UTILITY(U,$J,358.3,41598,1,4,0)
;;=4^I69.290
;;^UTILITY(U,$J,358.3,41598,2)
;;=^5007484
;;^UTILITY(U,$J,358.3,41599,0)
;;=I69.390^^155^2061^7
;;^UTILITY(U,$J,358.3,41599,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41599,1,3,0)
;;=3^Apraxia following cerebral infarction
;;^UTILITY(U,$J,358.3,41599,1,4,0)
;;=4^I69.390
;;^UTILITY(U,$J,358.3,41599,2)
;;=^5007515
;;^UTILITY(U,$J,358.3,41600,0)
;;=I69.190^^155^2061^8
;;^UTILITY(U,$J,358.3,41600,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41600,1,3,0)
;;=3^Apraxia following nontraumatic intracerebral hemorrhage
;;^UTILITY(U,$J,358.3,41600,1,4,0)
;;=4^I69.190
;;^UTILITY(U,$J,358.3,41600,2)
;;=^5007452
;;^UTILITY(U,$J,358.3,41601,0)
;;=I69.090^^155^2061^9
;;^UTILITY(U,$J,358.3,41601,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41601,1,3,0)
;;=3^Apraxia following nontraumatic subarachnoid hemorrhage
;;^UTILITY(U,$J,358.3,41601,1,4,0)
;;=4^I69.090
;;^UTILITY(U,$J,358.3,41601,2)
;;=^5007420
;;^UTILITY(U,$J,358.3,41602,0)
;;=I69.890^^155^2061^10
;;^UTILITY(U,$J,358.3,41602,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41602,1,3,0)
;;=3^Apraxia following other cerebrovascular disease
;;^UTILITY(U,$J,358.3,41602,1,4,0)
;;=4^I69.890
;;^UTILITY(U,$J,358.3,41602,2)
;;=^5007546
;;^UTILITY(U,$J,358.3,41603,0)
;;=I69.393^^155^2061^12
;;^UTILITY(U,$J,358.3,41603,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41603,1,3,0)
;;=3^Ataxia following cerebral infarction
;;^UTILITY(U,$J,358.3,41603,1,4,0)
;;=4^I69.393
;;^UTILITY(U,$J,358.3,41603,2)
;;=^5007518
;;^UTILITY(U,$J,358.3,41604,0)
;;=I69.193^^155^2061^13
;;^UTILITY(U,$J,358.3,41604,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,41604,1,3,0)
;;=3^Ataxia following nontraumatic intracerebral hemorrhage
;;^UTILITY(U,$J,358.3,41604,1,4,0)
;;=4^I69.193
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2LT 3769 printed Apr 09, 2024@21:11:31 Page 2
IBDEI2LT ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,41593,1,3,0)
+2 ;;=3^Aphasia following cerebral infarction
+3 ;;^UTILITY(U,$J,358.3,41593,1,4,0)
+4 ;;=4^I69.320
+5 ;;^UTILITY(U,$J,358.3,41593,2)
+6 ;;=^5007491
+7 ;;^UTILITY(U,$J,358.3,41594,0)
+8 ;;=I69.120^^155^2061^3
+9 ;;^UTILITY(U,$J,358.3,41594,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,41594,1,3,0)
+12 ;;=3^Aphasia following nontraumatic intracerebral hemorrhage
+13 ;;^UTILITY(U,$J,358.3,41594,1,4,0)
+14 ;;=4^I69.120
+15 ;;^UTILITY(U,$J,358.3,41594,2)
+16 ;;=^5007427
+17 ;;^UTILITY(U,$J,358.3,41595,0)
+18 ;;=I69.020^^155^2061^4
+19 ;;^UTILITY(U,$J,358.3,41595,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,41595,1,3,0)
+22 ;;=3^Aphasia following nontraumatic subarachnoid hemorrhage
+23 ;;^UTILITY(U,$J,358.3,41595,1,4,0)
+24 ;;=4^I69.020
+25 ;;^UTILITY(U,$J,358.3,41595,2)
+26 ;;=^5007395
+27 ;;^UTILITY(U,$J,358.3,41596,0)
+28 ;;=I69.820^^155^2061^5
+29 ;;^UTILITY(U,$J,358.3,41596,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,41596,1,3,0)
+32 ;;=3^Aphasia following other cerebrovascular disease
+33 ;;^UTILITY(U,$J,358.3,41596,1,4,0)
+34 ;;=4^I69.820
+35 ;;^UTILITY(U,$J,358.3,41596,2)
+36 ;;=^5007522
+37 ;;^UTILITY(U,$J,358.3,41597,0)
+38 ;;=I69.220^^155^2061^6
+39 ;;^UTILITY(U,$J,358.3,41597,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,41597,1,3,0)
+42 ;;=3^Aphasia following other nontraumatic intracranial hemorrhage
+43 ;;^UTILITY(U,$J,358.3,41597,1,4,0)
+44 ;;=4^I69.220
+45 ;;^UTILITY(U,$J,358.3,41597,2)
+46 ;;=^5007459
+47 ;;^UTILITY(U,$J,358.3,41598,0)
+48 ;;=I69.290^^155^2061^11
+49 ;;^UTILITY(U,$J,358.3,41598,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,41598,1,3,0)
+52 ;;=3^Apraxia following other nontraumatic intracranial hemorrhage
+53 ;;^UTILITY(U,$J,358.3,41598,1,4,0)
+54 ;;=4^I69.290
+55 ;;^UTILITY(U,$J,358.3,41598,2)
+56 ;;=^5007484
+57 ;;^UTILITY(U,$J,358.3,41599,0)
+58 ;;=I69.390^^155^2061^7
+59 ;;^UTILITY(U,$J,358.3,41599,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,41599,1,3,0)
+62 ;;=3^Apraxia following cerebral infarction
+63 ;;^UTILITY(U,$J,358.3,41599,1,4,0)
+64 ;;=4^I69.390
+65 ;;^UTILITY(U,$J,358.3,41599,2)
+66 ;;=^5007515
+67 ;;^UTILITY(U,$J,358.3,41600,0)
+68 ;;=I69.190^^155^2061^8
+69 ;;^UTILITY(U,$J,358.3,41600,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,41600,1,3,0)
+72 ;;=3^Apraxia following nontraumatic intracerebral hemorrhage
+73 ;;^UTILITY(U,$J,358.3,41600,1,4,0)
+74 ;;=4^I69.190
+75 ;;^UTILITY(U,$J,358.3,41600,2)
+76 ;;=^5007452
+77 ;;^UTILITY(U,$J,358.3,41601,0)
+78 ;;=I69.090^^155^2061^9
+79 ;;^UTILITY(U,$J,358.3,41601,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,41601,1,3,0)
+82 ;;=3^Apraxia following nontraumatic subarachnoid hemorrhage
+83 ;;^UTILITY(U,$J,358.3,41601,1,4,0)
+84 ;;=4^I69.090
+85 ;;^UTILITY(U,$J,358.3,41601,2)
+86 ;;=^5007420
+87 ;;^UTILITY(U,$J,358.3,41602,0)
+88 ;;=I69.890^^155^2061^10
+89 ;;^UTILITY(U,$J,358.3,41602,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,41602,1,3,0)
+92 ;;=3^Apraxia following other cerebrovascular disease
+93 ;;^UTILITY(U,$J,358.3,41602,1,4,0)
+94 ;;=4^I69.890
+95 ;;^UTILITY(U,$J,358.3,41602,2)
+96 ;;=^5007546
+97 ;;^UTILITY(U,$J,358.3,41603,0)
+98 ;;=I69.393^^155^2061^12
+99 ;;^UTILITY(U,$J,358.3,41603,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,41603,1,3,0)
+102 ;;=3^Ataxia following cerebral infarction
+103 ;;^UTILITY(U,$J,358.3,41603,1,4,0)
+104 ;;=4^I69.393
+105 ;;^UTILITY(U,$J,358.3,41603,2)
+106 ;;=^5007518
+107 ;;^UTILITY(U,$J,358.3,41604,0)
+108 ;;=I69.193^^155^2061^13
+109 ;;^UTILITY(U,$J,358.3,41604,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,41604,1,3,0)
+112 ;;=3^Ataxia following nontraumatic intracerebral hemorrhage
+113 ;;^UTILITY(U,$J,358.3,41604,1,4,0)
+114 ;;=4^I69.193
